Home > Balance Sheet > INDO US BIOTECH

INDO US BIOTECH
Total Non-Current Liabilities

    Back to Balance Sheet
INDO US BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results

INDO US BIOTECH Last 5 Year Total Non-Current Liabilities History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹2.29 Cr₹3.59 Cr₹2.09 Cr₹4.07 Cr₹3.92 Cr

What is the latest Total Non-Current Liabilities ratio of INDO US BIOTECH ?

The latest Total Non-Current Liabilities ratio of INDO US BIOTECH is ₹2.29 Cr based on Mar2025 Standalone results.
Year Total Non-Current Liabilities
Mar2025₹2.29 Cr
Mar2024₹3.59 Cr
Mar2023₹2.09 Cr
Mar2022₹4.07 Cr
Mar2021₹3.92 Cr

How is Total Non-Current Liabilities of INDO US BIOTECH Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹2.29 Cr
-36.14
Mar2024 ₹3.59 Cr
71.41
Mar2023 ₹2.09 Cr
-48.61
Mar2022 ₹4.07 Cr
3.96
Mar2021 ₹3.92 Cr -

Compare Total Non-Current Liabilities of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹205.7 Cr -27.3% -18.5% -44.6% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,717.0 Cr -6.5% -13.4% -5.5% Stock Analytics
KAVERI SEED COMPANY ₹3,946.2 Cr 2.5% -14.1% -24.8% Stock Analytics
VENKYS (INDIA) ₹1,783.1 Cr -2.8% -19.4% -19.6% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹875.1 Cr -1.5% -7.4% -34.7% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹327.9 Cr -1.3% -15.3% -29.7% Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

-27.3%

-18.5%

-44.6%

SENSEX

-4.6%

-7.5%

6%


You may also like the below Video Courses